Filing Details
- Accession Number:
- 0001493152-22-017168
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-17 16:17:40
- Reporting Period:
- 2022-06-15
- Accepted Time:
- 2022-06-17 16:17:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 318306 | Abeona Therapeutics Inc. | ABEO | Pharmaceutical Preparations (2834) | 830221517 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1356828 | Mark Alvino | 1330 Avenue Of The Americas, 33Rd Floor New York NY 10019 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-06-15 | 20,000 | $0.15 | 27,181 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Reflects the average weighted price of sales on June 15, 2022. The shares were sold in multiple transactions at prices ranging from $0.152 to $0.157, inclusive. The reporting person undertakes to provide Abeona Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Billionaire Hedge Funds
